1) L-lactic acid oligomer
L-乳酸低聚物
1.
Study on chain extension of L-lactic acid oligomer with isocyanate
L-乳酸低聚物的异氰酸酯扩链反应工艺研究
2.
It included the synthesis of L-lactic acid oligomer, the synthesis of L-lactide by L- lactic acid oligomer depolymerization and the establishment of detecting and analytical methods et al.
本文主要研究采用减压法合成L-丙交酯,其中包括L-乳酸低聚物的合成、L-乳酸低聚物的解聚制备L-丙交酯和分析测试方法的建立等工作。
2) Lactic acid Oligomer
乳酸低聚物
1.
In this paper,the structure characteristic of lactic acid and lactide are reviewed,The processes of synthesizing lactide by two-step technology are discussed,and the factors that influence the molecular mass of lactic acid oligomer and the yield of lactide are introduced.
对乳酸及丙交酯的结构特点进行了论述,介绍了两步法合成丙交酯的工艺以及影响乳酸低聚物分子质量和丙交酯产率的因素,提出了两步法合成丙交酯的研究方向。
3) poly(L-lactic acid)
聚L-乳酸
1.
Synthesis and characterization of poly(L-lactic acid)/polybutadiene based polyurethanes;
聚L-乳酸/聚丁二烯基聚氨酯的合成与表征
2.
Direct synthesis of poly(L-lactic acid) by melt polycondensation
熔融缩聚法直接合成聚L-乳酸的研究
4) poly(L-lactide)
聚L-乳酸
1.
The L-lactide was synthesized under the composite catalysts of Sn(II)2-ethyhexanoate (Zn(Oct)2) and ZnO, and the self-made organic solvent Sn(Oct)2 was used as the catalyst to synthesize poly(L-lactide).
为得到高分子质量的聚L-乳酸(Poly(L-lactide),PLLA),研究了包括L-丙交酯的制备、提纯、开环聚合以及合成工艺的影响因素和产物的性能评价等内容。
5) poly(l-lactide)
聚-L-乳酸
1.
The bone meals/PLLA composites used in internal fixation plates for bone surgery were prepared by bone meals and poly(L-lactide).
用骨粉和聚-L-乳酸复合制得骨粉/PLLA内固定复合材料,研究骨粉加入量对复合材料的力学性能的影响,对骨粉进行粒度分析和红外光谱分析,对制得的复合材料进行XRD和SEM表征。
6) Poly-L-lactide
聚-L-乳酸
1.
Poly-L-lactide/β-tricalcium phosphate composites (PLLA/β-TCP) were prepared and processed into bioresorbable rods with high strength for bone fixation by the method of compression molding.
本论文制备了可降解聚-L-乳酸(PLLA)/β-磷酸三钙(β-TCP)复合材料,详细研究了复合材料的取向模压、静电纺丝加工工艺,分别制得了高强度可吸收PLLA/β-TCP复合骨棒和PLLA/β-TCP纳米复合纤维膜。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条